In PLOS this week: genetic characterization of lager yeast, phylogenetic study of Rickettsia africae, and more.
The deal gives Oxford access to Imugen’s Lyme disease tests as well as PCR and immunoassay tests.
The firm expands its portfolio, providing customers with Dx for multiple applications
The test, which uses melt curve analysis and runs on a fully integrated platform from Zeesan, may have a head start on MDR and XDR tests from other companies.
Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.
In PLOS this week: founder mutation linked to some leukoencephalopathy cases, transcript and protein profiles of the kissing bug, and more.
A team in Spain used enhanced primer design, magnetic separation, and electrochemical detection to build a TB test as specific and sensitive as PCR.
The firm is using CMOS technology to develop a rapid TB test and other infectious disease panels, and is also partnering with other companies to enable tests.
In Nature this week: researchers uncover 13 healthy people who harbor Mendelian disease mutations, new tree of life, and more.
Researchers discussed using WGS to predict antibacterial resistance, to inform influenza vaccine development, and to diagnose and build drug resistance profiles for tuberculosis.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.
New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.
In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.